↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "L773:1869 6961 srt2:(2012-2014)"

Sökning: L773:1869 6961 > (2012-2014)

Resultat 1-8 av 8

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Ahmad Kiadaliri, Aliasghar, et al. (författare) Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in sweden. 2014 Ingår i: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6953. ; 5:2, s. 591-607 Tidskriftsartikel (refereegranskat)abstract This study aimed to assess the costs and benefits of three alternative second-line treatment strategies for Swedish patients with type 2 diabetes mellitus (T2DM) who fail to reach glycated hemoglobin (HbA1c)≤7% with metformin treatment alone: glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and neutral protamine Hagedorn (NPH) insulin.
2.	Ahrén, Bo, et al. (författare) Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities? 2014 Ingår i: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6953. Tidskriftsartikel (refereegranskat)abstract In a previously published study, vildagliptin showed a reduced risk of hypoglycemia versus glimepiride as add-on therapy to metformin at similar efficacy. Glimepiride was titrated from a starting dose of 2 mg/day to a maximum dose of 6 mg/day. It is usually assumed that the increased hypoglycemia with glimepiride was driven by the 6 mg/day dose; it was therefore of interest to assess whether the risk of hypoglycemia is also different between vildagliptin and a low (2 mg/day) dose of glimepiride.
3.	Bexelius, C, et al. (författare) Annual Medical Costs of Swedish Patients with Type 2 Diabetes Before and After Insulin Initiation 2013 Ingår i: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6953. ; 4:2, s. 363-374 Tidskriftsartikel (refereegranskat)
4.	Darpo, B, et al. (författare) Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study 2014 In: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6953. ; 5:1, s. 141-153 Journal article (peer-reviewed)
5.	Darpo, B, et al. (author) Erratum to: Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study 2014 In: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6953. ; 5:2, s. 609-609 Journal article (peer-reviewed)
6.	Eliasson, Björn, 1959, et al. (author) Metabolic Effects of Basal or Premixed Insulin Treatment in 5077 Insulin-Naïve Type 2 Diabetes Patients: Registry-Based Observational Study in Clinical Practice. 2014 In: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6953 .- 1869-6961. ; 5:1, s. 243-254 Journal article (peer-reviewed)abstract To investigate the clinical effects associated with premixed insulin (PM) and basal insulin [insulin NPH (NPH), insulin glargine (IG), insulin detemir (ID)], in insulin-naïve patients with type 2 diabetes in routine clinical care.
7.	Mathieu, C, et al. (author) Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE 2013 In: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6953. ; 4:2, s. 285-308 Journal article (peer-reviewed)
8.	Matthaei, S, et al. (author) Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study 2012 In: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6961. ; 3:1, s. 6- Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-8 of 8

Refine your search

Type of publication: journal article (8)

Type of content: peer-reviewed (8)

Author/Editor: OSTENSON, CG (2); Eliasson, Björn, 195 ... (2); Mathieu, C. (2); Matthews, J (2); Darpo, B (2); Perry, C. (2); show more...; Matthaei, S (2); Reaney, M (2); Zhou, MJ (2); Zhi, H (2); Young, MA (2); Reinhardt, RR (2); Guerci, B (2); Krarup, T (2); Theodorakis, M (2); Kiljański, J (2); Wang, X. (1); Lundberg, J. (1); Svensson, Ann-Marie, ... (1); Ahren, Bo (1); Odén, Anders, 1942 (1); Ahmad Kiadaliri, Ali ... (1); Gerdtham, Ulf (1); Steen Carlsson, Kata ... (1); Dejager, Sylvie (1); Schweizer, Anja (1); Foley, James Edward (1); Akacha, Mouna (1); Shao, Qing (1); Heimann, Guenter (1); Dworak, Markus (1); Berg, J (1); Bexelius, C (1); Hjelm, H (1); Ekström, Nils (1); Bruce Wirta, Sara (1); Fard, MirNabi Pirouz ... (1); Sapin, H (1); Salaun-Martin, C (1); Petto, H. (1); Bruhn, D (1); show less...

University: Karolinska Institutet (5); University of Gothenburg (2); Lund University (2); Chalmers University of Technology (1)

Language: English (8)

Research subject (UKÄ/SCB): Medical and Health Sciences (3)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view